Tennis elbow breakthrough? study seeks to identify PRP responders
NCT ID NCT07496983
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 139 adults with chronic tennis elbow who recently received a platelet-rich plasma (PRP) injection. Researchers want to find out how many people respond to PRP and what factors—like age, job, or health history—might predict a good outcome. Participants are followed for 90 days with pain and function tests. This is an observational study, not a test of a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LATERAL EPICONDYLITIS OF THE ELBOW are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles (CMRRF) de Kerpape
RECRUITINGPloemeur, 56270, France